Study participant died during Eisai’s Alzheimer’s drug trial October 31, 2022 AutoBot Uncategorized 0 A volunteer died during an Alzeheimer’s drug trial run by Tokyo-based drugmaker Eisai and Cambridge, Mass.-based Biogen. Eisai said the cause of death is unclear.